PROBLEM TO BE SOLVED: To provide: a compound or a pharmacologically acceptable salt thereof which inhibits a retinoic acid receptor-related orphan receptor and, due to suppression of Th-17 cell differentiation and/or suppression of IL-17 production, is effective for treatment and/or prevention of psoriasis, multiple sclerosis, rheumatic arthritis, inflammatory bowel disease, Sjogrens syndrome, systemic lupus erythematosus, chronic obstructive pulmonary disease, asthma, or colon cancer and a pharmaceutical composition containing the compound.SOLUTION: Provided are a compound represented by the following formula or a pharmacologically acceptable salt thereof, and a pharmaceutical composition containing the compound.SELECTED DRAWING: NoneCOPYRIGHT: (C)2016,JPO&INPIT【課題】レチノイン酸受容体関連オーファン受容体を阻害し、Th17細胞分化の抑制及び/又はIL-17産生の抑制による、乾癬、又は多発性硬化症、関節リウマチ、炎症性腸疾患、シェーグレン症候群、全身性エリテマトーデス、慢性閉塞性肺疾患、喘息、大腸癌等の治療、及び/又は予防に有効な化合物、又はその薬理上許容される塩、該化合物を含有する医薬組成物の提供。【解決手段】下記式に代表される化合物、又はその薬理上許容される塩、該化合物を含有する医薬組成物。【選択図】なし
